← All trials
NCT05888350
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 30, 2023
- Primary completion
- Mar 2, 2024
- Completion date
- Mar 30, 2024
- First posted
- Jun 5, 2023
- Last posted
- Jul 11, 2023
- Enrollment
- 520
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangzhou Medical UniversityLead sponsor
- Capital Medical UniversityCollaborator
- Peking UniversityCollaborator
- China Medical UniversityCollaborator
- Guangdong Provincial Hospital of Traditional Chinese MedicineCollaborator
- Henan Provincal People's HospitalCollaborator
- Huizhou Third People's HospitalCollaborator
- Inner Mongolia International Mongolian HospitalCollaborator
- Southern Medical UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jilin UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Shenzhen UniversityCollaborator
- Guangzhou Medical UniversityReponsible party - principal investigator
- Guangzhou Medical UniversityStudy chair
- Henan Medical UniversityCollaborator
- Shanxi Medical UniversityCollaborator
- The First People's Hospital of Yunan ProvinceCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Zunyi Medical CollegeCollaborator
- Guangzhou Medical UniversitySponsor investigator
- Guangzhou Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.